Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction
Clinical trial NCT05410925 · RECRUITING
Trial details
- NCT number
- NCT05410925
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-08
- Primary completion
- 2026-12-31
- Enrollment
- 2260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.